Novotech Signs Strategic MOU with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL)

Contributed by: GlobeNewswire

Tags

biotech

More Like This

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

Novotech and Biostar Pharma Partnership (Photo: Business Wire)

Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024

Novotech Announces MOU with Experienced Psychedelics Research Center at the 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston

Novotech Launches Dedicated Early Phase Unit for Biotechs Leveraging the Australian and New Zealand Clinical Environment

Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award

2024 Clinical Trials Arena Excellence Award Winner Presented to Novotech (Graphic: Business Wire)

Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023